Shares of Forty Seven Inc. (FTSV) are up more than 22 percent in pre-market trading on Friday, following reports that Gilead Sciences, Inc. (GILD) is interested in acquiring the clinical-stage, immuno-oncology company.
from RTT - Biotech https://ift.tt/2wQCgZb
via IFTTT
No comments:
Post a Comment